Stanford University
Showing 30,661-30,680 of 34,420 Results
-
Stephanie Van de Ven
Member, Stanford Cancer Institute
BioAs Deputy Director of the Canary Center at Stanford for Cancer Early Detection I broadly oversee its operations and research programs. The Canary Center is focused on developing in vitro and in vivo tools for early cancer detection and its research spans the areas of biomarker discovery, development of molecular imaging agents, development of new diagnostic and imaging devices, and mathematical modeling. In my position I facilitate the clinical translation of cancer diagnostic tools and I enable innovative interdisciplinary research. My research expertise includes leading phase I-II clinical trials to evaluate a newly developed optical breast imaging system in combination with a novel imaging agent. I gained valuable experience in clinical translation of medical devices and in testing new imaging agents for the first time in patients. My training as a Radiology resident was instrumental in my decision to focus on cancer early detection research, because it clearly confronted me with the problem that most cancer patients are being diagnosed too late. I expanded my knowledge on biomarker research by developing proteomics assays during my postdoctoral fellowship at Stanford, in conjunction with my continued work in optical and photoacoustic molecular imaging. In my current role, I work with the faculty of the Canary Center and the Molecular Imaging Program at Stanford, and am committed to advancing cancer research by applying my medical training, clinical knowledge, and research expertise to managing collaborative programs and contribute to the success of the Center and its faculty.
-
Pieter van der Starre
Professor of Anesthesiology, Perioperative and Pain Medicine at the Stanford University Medical Center, Emeritus
Current Research and Scholarly InterestsCardiovascular Pharmacology, Cardiovascular Physiology,
Neurophysiology and Monitoring,
Transesophageal Echocardiography -
Tim B van Driel
Lead Scientist, LCLS - Linac Coherent Light Source
BioTim van Driel is a Lead Scientist at the Linac Coherent Light Source (LCLS) within the SLAC National Accelerator Laboratory with over a decade of experience as a subject matter expert. His research focuses on ultrafast time-resolved chemical dynamics, and he is currently leading the development of the LCLS-II-HE Condensed Phase Chemistry endstation. His efforts span experimental design, precision instrumentation and diagnostics, detector improvements, and advanced analysis frameworks to capture the non-equilibrium evolution of complex chemical systems. By directing "molecular movies," his work aims to visualize and control the fleeting dynamics of structure, spin, and charge that dictate performance from isolated molecules to energy and quantum materials. Dr. van Driel leads the deployment and development of the Liquid Jet Endstation (LJE) at LCLS, a specialized platform enabling femtosecond resolution measurements of photochemical and solvation processes.
Increasingly, his work focuses on the intersection of ultrafast multimodal X-ray science and artificial intelligence. Dr. van Driel is pioneering the integration of AI/ML into complex experimental workflows from dimensional reduction, improved signal to noise as well as automated pipelines and cross experiment scientific insights. He is also a key member of the ISAAC pathfinder project to autonomously guide and accelerate scientific discovery in catalysis across multiple national laboratories, seamlessly combining massive multimodal datasets with advanced theoretical models.
He received his Ph.D. in Physics from the Technical University of Denmark and his M.Sc. in Nanoscience from the University of Copenhagen. At SLAC, he is also deeply involved in pursuing new scientific directions and engaging with the larger community as the Secretary for the Peer Review Panel (PRP) for Chemistry, Soft Condensed Matter & Disordered Materials (CSD) and as an LCLS Culture Champion.
